<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Argentina</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Argentina.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/countries/ar.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Clinical and Analytical Performance of the AP Biotech Discovery® Dengue Virus RT-PCR Detection Kit</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3390-v18080914-4f6b059b/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3390-v18080914-4f6b059b/</guid>
    <pubDate>Thu, 20 Aug 2026 00:00:00 GMT</pubDate>
    <description>A sensitive and specific RT-PCR assay for early dengue detection across all four serotypes may support clinical diagnosis and epidemiologic surveillance, particularly in endemic tropical and subtropical regions with rising incidence.</description>
    <category>Dengue</category>
    <category>Surveillance</category>
    <category>Diagnostics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Invasive pneumococcal disease in Latin America: serotype distribution and vaccine coverage among adults in Mexico, Brazil, and Argentina</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128947-dcbe5378/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128947-dcbe5378/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings provide country- and age-specific estimates of the proportion of adult invasive pneumococcal disease associated with serotypes covered by available vaccines. The analysis indicates that PCV21 had broader estimated serotype coverage than the other vaccines assessed, while the abstract does not measure vaccination-program implementation, vaccine effectiveness, or reductions in disease after vaccination.</description>
    <category>Invasive pneumococcal disease</category>
    <category>Vaccination</category>
    <category>Surveillance</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>Genomic characterization of XDR Mycobacterium tuberculosis isolates in Argentina (2006–2015)</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-025-11913-3-efc4836a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-025-11913-3-efc4836a/</guid>
    <pubDate>Mon, 17 Nov 2025 00:00:00 GMT</pubDate>
    <description>The findings provide genomic context for XDR-TB resistance-associated variation in the studied Argentine isolates. The authors state that the results support continued research and surveillance efforts, but the abstract does not quantify population-level effects or clinical outcomes.</description>
    <category>Tuberculosis</category>
    <category>Antimicrobial resistance</category>
    <category>Surveillance</category>
    <category>Genomic epidemiology</category>
    <category>Treatment</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>Urban vectors of Chagas disease in the American continent: A systematic review of epidemiological surveys</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0011003-dbad51b5/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0011003-dbad51b5/</guid>
    <pubDate>Wed, 14 Dec 2022 00:00:00 GMT</pubDate>
    <description>Urban Chagas disease represents an emerging challenge that adds complexity to disease control due to distinct characteristics of urban lifestyles and agglomerations. The shift from rural to urban vector transmission requires adaptation of existing vector control programs.</description>
    <category>Chagas disease</category>
    <category>Transmission dynamics</category>
    <category>Climate and environment</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Evaluation of a social protection policy on tuberculosis treatment outcomes: A prospective cohort study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pmed-1002788-35691d90/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pmed-1002788-35691d90/</guid>
    <pubDate>Tue, 30 Apr 2019 00:00:00 GMT</pubDate>
    <description>The authors suggest the cash transfer policy may be a useful intervention to improve tuberculosis treatment outcomes in similar high-burden settings.</description>
    <category>Tuberculosis</category>
    <category>Treatment</category>
    <category>Health policy</category>
    <category>Climate and environment</category>
    <category>Antimicrobial resistance</category>
    <category>Cohort study</category>
  </item>
  <item>
    <title>Four decades of transmission of a multidrug-resistant Mycobacterium tuberculosis outbreak strain</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-ncomms8119-cd0d9ec2/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-ncomms8119-cd0d9ec2/</guid>
    <pubDate>Mon, 11 May 2015 00:00:00 GMT</pubDate>
    <description>The findings demonstrate that multidrug-resistant and extensively drug-resistant tuberculosis strains can circulate undetected for prolonged periods, underscoring challenges in early detection and control of resistant tuberculosis.</description>
    <category>Tuberculosis</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Antimicrobial resistance</category>
    <category>Journal article</category>
  </item>
</channel>
</rss>
